Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 183

    1.

    Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors.

    Tsokos GC, Gorden P, Antonovych T, Wilson CB, Balow JE.

    Ann Intern Med. 1985 Feb;102(2):176-81.PMID: 3966755 [PubMed - indexed for MEDLINE]Related articles

    2.

    Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.

    Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, Ogg CS.

    Q J Med. 1983 Autumn;52(208):471-87.PMID: 6606818 [PubMed - indexed for MEDLINE]Related articles

    3.

    [Lupus, insulin-resistant diabetes and acanthosis nigricans (author's transl)]

    Wechsler B, Michel JP, Molle D, Wechsler J, Franceschini P, Liozon F, Godeau P.

    Ann Dermatol Venereol. 1981;108(1):23-30. French. PMID: 7235501 [PubMed - indexed for MEDLINE]Related articles

    4.

    Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.

    Baird JS, Johnson JL, Elliott-Mills D, Opas LM.

    Lupus. 1997;6(3):275-8.PMID: 9104736 [PubMed - indexed for MEDLINE]Related articles

    5.

    Induction of insulin resistance by autoantibodies to insulin receptors following on an acute Coxsackie B4 infection.

    el-Reshaid K, al-Mofti S, Stepic NR.

    Diabetes Res Clin Pract. 1994 Oct;25(3):207-10.PMID: 7851276 [PubMed - indexed for MEDLINE]Related articles

    6.

    Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus.

    Moller DE, Ratner RE, Borenstein DG, Taylor SI.

    Am J Med. 1988 Feb;84(2):334-8. Review.PMID: 3044073 [PubMed - indexed for MEDLINE]Related articles

    7.

    Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.

    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.

    Scand J Rheumatol. 2007 Jul-Aug;36(4):291-8.PMID: 17763207 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lupus-like nephritis heralding the definitive manifestation of systemic lupus erythematosus.

    Fisher C, Gibb WR, Cohen SL, Collins CR, Potter A, Isenberg DA.

    Br J Rheumatol. 1985 Aug;24(3):256-62.PMID: 3874672 [PubMed - indexed for MEDLINE]Related articles

    9.

    Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.

    Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC.

    Ann Rheum Dis. 1993 Dec;52(12):851-6.PMID: 8311534 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The evolving clinical course of patients with insulin receptor autoantibodies: spontaneous remission or receptor proliferation with hypoglycemia.

    Flier JS, Bar RS, Muggeo M, Kahn CR, Roth J, Gorden P.

    J Clin Endocrinol Metab. 1978 Nov;47(5):985-95.PMID: 263346 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.

    do Nascimento AP, Viana Vdos S, Testagrossa Lde A, Leon EP, Borba EF, Barros RT, Bonfá E.

    Arthritis Rheum. 2006 May;54(5):1568-72.PMID: 16645990 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Association of type I (insulin-dependent) diabetes mellitus, autoimmunity, antinuclear antibody, and membranoproliferative glomerulonephritis.

    Srikanta S, Malaviya AN, Rajagopalan P, Bhuyan UN, Ahuja MM.

    Diabetes Care. 1983 Jan-Feb;6(1):71-4.PMID: 6220878 [PubMed - indexed for MEDLINE]Related articles

    13.

    Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.

    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.

    Arthritis Res Ther. 2006;8(6):R162.PMID: 17062137 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.

    Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG.

    J Autoimmun. 2006 May;26(3):165-71. Epub 2006 Apr 18.PMID: 16621447 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Abnormal insulin receptor type-B associated with lupus erythematosus]

    Saito N, Usami K, Miyazaki M, Nishimaki T, Yoshida H, Kasukawa R, Asano S, Kamiyama S, Wakasa H, Goto K.

    Nippon Rinsho. 1983 Oct;41(10):2412-20. Japanese. No abstract available. PMID: 6668704 [PubMed - indexed for MEDLINE]Related articles

    17.

    Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.

    Li QZ, Zhou J, Wandstrat AE, Carr-Johnson F, Branch V, Karp DR, Mohan C, Wakeland EK, Olsen NJ.

    Clin Exp Immunol. 2007 Jan;147(1):60-70.PMID: 17177964 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment.

    Woolf A, Croker B, Osofsky SG, Kredich DW.

    Pediatrics. 1979 Nov;64(5):678-85.PMID: 386241 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.

    Baranowska-Daca E, Choi YJ, Barrios R, Nassar G, Suki WN, Truong LD.

    Hum Pathol. 2001 Oct;32(10):1125-35.PMID: 11679948 [PubMed - indexed for MEDLINE]Related articles

    20.

    Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus.

    Cortés-Hernández J, Ordi-Ros J, Labrador M, Buján S, Balada E, Segarra A, Vilardell-Tarrés M.

    Am J Med. 2004 Feb 1;116(3):165-73.PMID: 14749160 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data